IBA Dosimetry America

+1 901 386 2242http://www.iba-dosimetry.com

Request Information

IBA releases the second version of myQA®: Global QA Platform Further enhancing user connectivity and benchmarking via the Cloud

Extending the frontiers in highly efficient and effective QA workflows

IBA (Ion Beam Applications S.A.), the global high-tech leader in the next generation of proton therapy solutions and radiation therapy dosimetry for the treatment of cancer, announces the second release of the new global quality assurance platform: myQA®. myQA is a unique platform that connects QA applications, people, and know-how through a Central Database and the Cloud. It offers full support to its users throughout the entire QA workflow, and provides access to all software modules and data from one intuitive interface.  
“It has been a remarkable journey thus far and we are proud to offer our customers the second release in only six months. Our goal is to continuously advance and upgrade myQA to the needs of our users and the demands of the market. IBA takes pride in assisting our customers to not only stay compliant, but also giving them the highest level of quality and efficiency in their QA. By communicating our continual growth model and benefits given through myQA Coverage, I trust that our customers have recognized our dedication to this goal. With upcoming installments already in the works, we are extremely excited to continue on this myQA journey!” says Bruno Marchand, Vice President of Research and Development at IBA Dosimetry.
Since the initial release of myQA in March of this year, it has gained tremendous recognition,
enthusiasm, and support from the radiation therapy community. Being the first and only of it’s kind;
myQA is extending the frontiers in highly efficient and effective QA workflows. With the release of the highly anticipated myQA Cloud, the Support Portal, an even more advanced patient dashboard within myQA Cockpit, and much more, the evolution of myQA is proving its commitment to providing users with the latest and most advanced QA solution.  
myQA Cloud offers users the valuable opportunity to anonymously benchmark their QA data and
connect with users from around the world. This online tool not only contributes to best practice checks, but also gives its users full trust in their results. With the upgrade of myQA Cockpit, users are able to better track, review, and maintain their patient QA data on one interface. This new addition allows users to comfortably monitor their patient and machine QA data in one place and on any web-accessible device. myQA Cockpit is the gift of ultimate mobility and convenience.  
“We at IBA always strive to provide the best services in the industry to our customers. To continue in this direction, myQA users now receive the extraordinary benefits of myQA Coverage,” says Christian Kling, Vice President of Logistics and Services at IBA Dosimetry. This includes a 24/7 hotline to speak directly with our professionally trained service staff as well as the newly released online Support Portal. This incredible tool has also been integrated into the myQA Platform for fast and convenient access. IBA’s Support Portal takes a great leap forward in helping our customers with all of their dosimetry questions – 24 hours a day, 7 days a week. We have already received a great deal of positive feedback from customers all over the world, as well as useful input that drives us to further develop and continuously improve our customer service. I’m looking forward to the exciting new functionalities that each future implementation and release will offer.”
About IBA
IBA  (Ion  Beam  Applications  S.A.)  is  a  global  medical  technology  company  focused  on  bringing integrated  and  innovative  solutions  for  the  diagnosis  and  treatment  of  cancer.  The  Company  is  the worldwide technology leader in the field of proton therapy, the most advanced form of radiation therapy available  today.  IBA’s  proton  therapy  solutions  are  flexible  and  adaptable,  allowing  customers  to choose  from  universal full-scale proton  therapy  centers  as  well  as  compact,  single  room  systems.    In addition, IBA also has a radiation dosimetry business and develops particle accelerators for the medical world and industry.
Headquartered  in  Belgium  and  employing  about  1100  people  worldwide,  IBA  has  installed  systems across  the  world,  from  Europe  and  the  US  and  to  the  emerging  markets.    IBA  is  listed  on  the  pan-European  stock  exchange  EURONEXT.  (IBA:  Reuters  IBAB.BR  and  Bloomberg  IBAB.BB)  and  more information can be found at: www.iba-worldwide.com
Media Contact:  
Jacqueline McMahon
IBA Dosimetry GmbH
Bahnhofstr. 5
90592 Schwarzenbruck, Germany
Tel: 49 9128 607 0

What’s new

Search all our content